Table of Contents 1 Communicable Diseases Therapeutics Market Overview 1.1 Communicable Diseases Therapeutics Product Overview 1.2 Communicable Diseases Therapeutics Market Segment by Type 1.2.1 HIV 1.2.2 Influenza 1.2.3 TB 1.2.4 Malaria 1.2.5 Hepatitis 1.2.6 HPV 1.3 Global Communicable Diseases Therapeutics Market Size by Type 1.3.1 Global Communicable Diseases Therapeutics Sales and Growth by Type 1.3.2 Global Communicable Diseases Therapeutics Sales and Market Share by Type (2014-2019) 1.3.3 Global Communicable Diseases Therapeutics Revenue and Market Share by Type (2014-2019) 1.3.4 Global Communicable Diseases Therapeutics Price by Type (2014-2019) 2 Global Communicable Diseases Therapeutics Market Competition by Company 2.1 Global Communicable Diseases Therapeutics Sales and Market Share by Company (2014-2019) 2.2 Global Communicable Diseases Therapeutics Revenue and Share by Company (2014-2019) 2.3 Global Communicable Diseases Therapeutics Price by Company (2014-2019) 2.4 Global Top Players Communicable Diseases Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 2.5 Communicable Diseases Therapeutics Market Competitive Situation and Trends 2.5.1 Communicable Diseases Therapeutics Market Concentration Rate 2.5.2 Global Communicable Diseases Therapeutics Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Communicable Diseases Therapeutics Company Profiles and Sales Data 3.1 Novartis 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.1.3 Novartis Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Gilead 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.2.3 Gilead Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 GSK 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.3.3 GSK Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Janssen Pharmaceutical 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.4.3 Janssen Pharmaceutical Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Roche 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.5.3 Roche Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 BioCryst Pharmaceuticals 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.6.3 BioCryst Pharmaceuticals Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Merck 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.7.3 Merck Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 Boehringer Ingelheim 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Communicable Diseases Therapeutics Product Category, Application and Specification 3.8.3 Boehringer Ingelheim Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 4 Communicable Diseases Therapeutics Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Communicable Diseases Therapeutics Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Communicable Diseases Therapeutics Sales and Revenue by Regions 4.2.1 Global Communicable Diseases Therapeutics Sales and Market Share by Regions (2014-2019) 4.2.2 Global Communicable Diseases Therapeutics Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Communicable Diseases Therapeutics Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Communicable Diseases Therapeutics Application/End Users 5.1 Communicable Diseases Therapeutics Segment by Application 5.1.1 Hospital 5.1.2 Clinic 5.1.3 Other 5.2 Global Communicable Diseases Therapeutics Product Segment by Application 5.2.1 Global Communicable Diseases Therapeutics Sales by Application 5.2.2 Global Communicable Diseases Therapeutics Sales and Market Share by Application (2014-2019) 6 Global Communicable Diseases Therapeutics Market Forecast 6.1 Global Communicable Diseases Therapeutics Sales, Revenue Forecast (2019-2025) 6.1.1 Global Communicable Diseases Therapeutics Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Communicable Diseases Therapeutics Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Communicable Diseases Therapeutics Forecast by Regions 6.2.1 North America Communicable Diseases Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Communicable Diseases Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Communicable Diseases Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Communicable Diseases Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Communicable Diseases Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Communicable Diseases Therapeutics Forecast by Type 6.3.1 Global Communicable Diseases Therapeutics Sales and Revenue Forecast by Type (2019-2025) 6.3.2 HIV Gowth Forecast 6.3.3 Influenza Gowth Forecast 6.4 Communicable Diseases Therapeutics Forecast by Application 6.4.1 Global Communicable Diseases Therapeutics Sales Forecast by Application (2019-2025) 6.4.2 Global Communicable Diseases Therapeutics Forecast in Hospital 6.4.3 Global Communicable Diseases Therapeutics Forecast in Clinic 7 Communicable Diseases Therapeutics Upstream Raw Materials 7.1 Communicable Diseases Therapeutics Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Communicable Diseases Therapeutics Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Communicable Diseases Therapeutics Product Picture Figure Global Communicable Diseases Therapeutics Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Communicable Diseases Therapeutics Sales (K Units) Status and Outlook (2014-2025) Figure Product Picture of HIV Table Major Players of HIV Figure Global HIV Sales (K Units) and Growth Rate (%)(2014-2018) Figure Product Picture of Influenza Table Major Players of Influenza Figure Global Influenza Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of TB Table Major Players of TB Figure Global TB Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Malaria Table Major Players of Malaria Figure Global Malaria Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Hepatitis Table Major Players of Hepatitis Figure Global Hepatitis Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of HPV Table Major Players of HPV Figure Global HPV Sales (K Units) and Growth Rate (%)(2014-2019) Table Global Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Type Table Global Communicable Diseases Therapeutics Sales (K Units) by Type (2014-2019) Table Global Communicable Diseases Therapeutics Sales Share (%) by Type (2014-2019) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) by Type (2014-2019) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) by Type in 2018 Table Global Communicable Diseases Therapeutics Revenue (Million USD) by Type (2014-2019) Table Global Communicable Diseases Therapeutics Revenue Share (%) by Type (2014-2019) Figure Global Communicable Diseases Therapeutics Revenue Share (%) by Type (2014-2019) Figure 2018 Global Communicable Diseases Therapeutics Revenue Market Share (%) by Type Table Global Communicable Diseases Therapeutics Price (USD/Unit) by Type (2014-2019) Table Global Communicable Diseases Therapeutics Sales (K Units) by Company (2014-2019) Table Global Communicable Diseases Therapeutics Sales Share (%) by Company (2014-2019) Figure Global Communicable Diseases Therapeutics Sales Share (%) by Company in 2018 Table Global Communicable Diseases Therapeutics Revenue (Million USD) by Company (2014-2019) Table Global Communicable Diseases Therapeutics Revenue Share (%) by Company (2014-2019) Figure Global Communicable Diseases Therapeutics Revenue Share (%) by Company in 2018 Table Global Market Communicable Diseases Therapeutics Average Price (USD/Unit) by Company (2014-2019) Table Global Communicable Diseases Therapeutics Top Players Manufacturing Base Distribution and Sales Area Table Global Communicable Diseases Therapeutics Top Players Product Category Figure Global Communicable Diseases Therapeutics Market Share (%) of Top 5 Players Figure Global Communicable Diseases Therapeutics Market Share (%) of Top 10 Players Table Novartis Basic Information List Table Novartis Communicable Diseases Therapeutics Product Category, Application and Specification Table Novartis Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Novartis Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure Novartis Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table Gilead Basic Information List Figure Gilead Communicable Diseases Therapeutics Product Category, Application and Specification Table Gilead Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Gilead Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure Gilead Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table GSK Basic Information List Figure GSK Communicable Diseases Therapeutics Product Category, Application and Specification Table GSK Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure GSK Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure GSK Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table Janssen Pharmaceutical Basic Information List Figure Janssen Pharmaceutical Communicable Diseases Therapeutics Product Category, Application and Specification Table Janssen Pharmaceutical Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Janssen Pharmaceutical Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure Janssen Pharmaceutical Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table Roche Basic Information List Figure Roche Communicable Diseases Therapeutics Product Category, Application and Specification Table Roche Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Roche Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure Roche Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table BioCryst Pharmaceuticals Basic Information List Figure BioCryst Pharmaceuticals Communicable Diseases Therapeutics Product Category, Application and Specification Table BioCryst Pharmaceuticals Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure BioCryst Pharmaceuticals Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure BioCryst Pharmaceuticals Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table Merck Basic Information List Figure Merck Communicable Diseases Therapeutics Product Category, Application and Specification Table Merck Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Merck Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure Merck Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table Boehringer Ingelheim Basic Information List Figure Boehringer Ingelheim Communicable Diseases Therapeutics Product Category, Application and Specification Table Boehringer Ingelheim Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Boehringer Ingelheim Communicable Diseases Therapeutics Sales Growth Rate (2014-2019) Figure Boehringer Ingelheim Communicable Diseases Therapeutics Sales Global Market Share (%)(2014-2019) Table Global Communicable Diseases Therapeutics Market Size Comparison by Regions (2014-2025) Figure North America Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Communicable Diseases Therapeutics Sales (K Units) by Regions (2014-2019) Table Global Communicable Diseases Therapeutics Sales Market Share (%) by Regions (2014-2019) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Communicable Diseases Therapeutics Sales Market Share (%) by Regions Table Global Communicable Diseases Therapeutics Revenue (Million USD) by Regions (2014-2019) Table Global Communicable Diseases Therapeutics Revenue Market Share (%) by Regions (2014-2019) Figure Global Communicable Diseases Therapeutics Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Communicable Diseases Therapeutics Revenue Market Share (%) by Regions Table Global Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure North America Communicable Diseases Therapeutics Sales Growth Rate Table North America Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure United States Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure United States Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Canada Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Canada Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Mexico Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Mexico Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Europe Communicable Diseases Therapeutics Sales Growth Rate Table Europe Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Germany Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Germany Communicable Diseases Therapeutics Revenue (Million USD) (2014-2019) Figure UK Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure UK Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure France Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure France Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Italy Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Italy Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Russia Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Russia Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Turkey Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Turkey Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Asia-Pacific Communicable Diseases Therapeutics Sales Growth Rate Table Asia-Pacific Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure China Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure China Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Japan Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Japan Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Korea Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Korea Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Southeast Asia Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Southeast Asia Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Indonesia Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Indonesia Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Thailand Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Thailand Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Malaysia Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Malaysia Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Philippines Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Philippines Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Vietnam Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Vietnam Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure India Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure India Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Australia Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Australia Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure South America Communicable Diseases Therapeutics Sales Growth Rate Table South America Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Brazil Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure Brazil Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Middle East and Africa Communicable Diseases Therapeutics Sales Growth Rate Table Middle East and Africa Communicable Diseases Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure North Africa Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure North Africa Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure GCC Countries Communicable Diseases Therapeutics Sales (K Units)(2014-2019) Figure GCC Countries Communicable Diseases Therapeutics Revenue (Million USD)(2014-2019) Figure Hospital Examples Figure Clinic Examples Figure Other Examples Table Global Communicable Diseases Therapeutics Sales (K Units) Comparison by Application (2014-2025) Table Global Communicable Diseases Therapeutics Sales (K Units) by Application (2014-2019) Table Global Communicable Diseases Therapeutics Sales Share (%) by Application (2014-2019) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) by Application (2014-2019) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) by Application in 2018 Figure Global Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Global Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Communicable Diseases Therapeutics Sales (K Units) Forecast by Regions (2019-2025) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure North America Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Europe Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure China Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Japan Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Korea Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure India Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Australia Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure South America Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Communicable Diseases Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Communicable Diseases Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Communicable Diseases Therapeutics Sales (Million USD) Forecast by Type (2019-2025) Figure Global Communicable Diseases Therapeutics Sales Market Share (%) Forecast by Type (2019-2025) Table Global Communicable Diseases Therapeutics Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Communicable Diseases Therapeutics Revenue Market Share (%) Forecast by Type (2019-2025) Figure HIV Sales Growth Forecast Figure Influenza Sales Growth Forecast Table Global Communicable Diseases Therapeutics Sales (K Units) Forecast by Application (2019-2025) Figure Global Communicable Diseases Therapeutics Sales Forecast by Application (2019-2025) Figure Global Communicable Diseases Therapeutics Sales (K Units) Forecast in Hospital Figure Global Communicable Diseases Therapeutics Sales (K Units) Forecast in Clinic Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Communicable Diseases Therapeutics Manufacturing Cost Structure Figure Communicable Diseases Therapeutics Industrial Chain Analysis Table Distributors List Table Communicable Diseases Therapeutics Downstream Customers

Novartis Gilead GSK Janssen Pharmaceutical Roche BioCryst Pharmaceuticals Merck Boehringer Ingelheim